JXG: Shunt, Central Nervous System And Components: FDA Product Code 510(k) Clearances, Predicate Lineage, and Recall History (1976 to 2026)
U.S. FDA CDRH three-letter product classification JXG in Neurology (21 CFR 882.5550) reconciled across 1976 to 2026.
Review 260 FDA 510(k) clearances, 53 recalled K-numbers, and 109 cumulative 1976 to 2026 CDRH recall notices for JXG: Shunt, Central Nervous System And Components on Predicate Ledger.
| Regulatory Metric | Verified Value |
|---|---|
| Entity Classification | FDA 3-Letter Product Code (JXG, Class 2) |
| Clinical Advisory Specialty | Neurology (Panel NE) |
| Cleared FDA 510(k) Submissions (1976 to 2026) | 260 clearances (50 California, 19.2%) |
| Cleared 510(k)s Linked to a Recall Notice | 53 K-numbers (20.38% of cleared cohort) |
| Cumulative Historical Recall Notices (1976 to 2026) | 109 notices (9 Class I, 99 Class II, 1 Class III) |
| Currently Open vs Historical Recall Status | Cumulative 1976 to 2026 FDA archive total (109 notices); verify live open vs terminated status per notice in dossier |
| Implantable and Life-Sustaining Clearances | 260 implantable (100.0%) and 0 life-sustaining |
| Median FDA 510(k) Review Duration | 90 days (90th percentile: 271 days) |
Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.